These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2408060)

  • 1. CD9 is an unreliable antibody for bone marrow purging.
    Fort JA; Rios AM; Gross S; Janssen WE
    Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
    Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
    Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
    Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
    Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
    Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
    Janssen WE; Lee C; Gross S; Gee AP
    Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
    De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
    Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
    Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
    Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
    Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
    Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia].
    Baryshnikov AIu; Tupitsyn NN; Korotkova OV; Kadagidze ZG; Dostot E; Shmidt M; Boumsell L
    Eksp Onkol; 1989; 11(5):52-3. PubMed ID: 2529115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin.
    Masellis-Smith A; Shaw AR
    J Immunol; 1994 Mar; 152(6):2768-77. PubMed ID: 7511626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibody and purging].
    Ueda R; Morishima Y
    Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
    Bai Y; Piao XH; Luo QL; Mao BZ
    Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia.
    Vervoordeldonk SF; van den Berg H; von dem Borne AE; van Leeuwen EF; Slaper-Cortenbach IC
    J Hematother; 1997 Oct; 6(5):495-500. PubMed ID: 9368186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.